Antineoplastic Agents

3 researchers across 1 institution

3 Researchers
1 Institutions
0 Grant PIs
0 High Impact

Researchers investigate the development and evaluation of compounds designed to inhibit or destroy cancerous cells. This work involves identifying novel molecular targets within cancer cells, synthesizing potential therapeutic agents, and assessing their efficacy and safety through various experimental models. Studies explore mechanisms of action, drug resistance, and the optimization of drug delivery systems. Areas of focus include the discovery of new antineoplastic agents from diverse sources, including natural products, and the exploration of their biochemical pathways.

This research holds significance for Arkansas by addressing public health needs related to cancer incidence and mortality. The development of new cancer therapies can contribute to improved patient outcomes and potentially reduce healthcare burdens within the state. Furthermore, exploring natural products for therapeutic potential aligns with Arkansas's agricultural and forestry sectors, offering opportunities for innovation in bio-based industries and the sustainable utilization of natural resources.

This area of study intersects with investigations into cancer-related molecular mechanisms, receptor signaling, and the pharmacological effects of various substances. Collaboration extends across multiple institutions, fostering a comprehensive approach to understanding and combating cancer.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Suman Kumar Samanta UAMS 18 954
Narasimhappagari Jagadeesh UAMS 6 105
Megan Taylor UAMS 1 26

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
7,294 works in 2025
+10.5% CAGR 2018–2025
Leadership concentration
1.6% held by global top 5 institutions
Fragmented HHI 2
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2025 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 500
  2. 2 Memorial Sloan Kettering Cancer Center 425
  3. 3 Harvard University 322
  4. 4 Mayo Clinic in Arizona 258
  5. 5 Mayo Clinic 247
Browse All 3 Researchers in Directory